Lalco Pharma Private Limited

Lalco Pharma Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U24239DL2000PTC104377 Incorporated 13 March 2000 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2025
₹21.01 Cr
▼ 4% YoY
Net profit · FY 2025
₹25.53 Lakh
Net margin 1.2%
EBITDA · FY 2025
₹66.94 Lakh
EBITDA margin 3.2%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹14 Lakh
Issued & subscribed
Open charges
₹6.22 Cr
Secured borrowings
Company age
26 yrs
Est. 2000
Directors on board
4
As per MCA filings

About Lalco Pharma Private Limited

Data last updated:

Lalco Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 March 2000 and has been in existence for over 26 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2000PTC104377. Its GSTIN is 07AAACL7439D1ZM (Delhi).

The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹14 Lakh. It is led by directors including Abhay Kumar Agarwal (Managing Director) and Atul Kumar Agarwal.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 62/14 Old Rajinder Nagar, New Delhi, Delhi, India – 110060.

As per the financials filed for FY 2025, the company reported a revenue of ₹21.01 Cr, a decline of 4% compared to the previous year. For the same year it recorded a net profit of ₹25.53 Lakh (net margin 1.2%) and EBITDA of ₹66.94 Lakh (EBITDA margin 3.2%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 2% over five years.

As per MCA filings, the company has open charges of ₹6.22 Cr on record. Court records list 1 case involving the company, including 1 filed against it.

Lalco Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-01-0006852). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24239DL2000PTC104377
Registration Number 104377
Incorporation Date 13 March 2000
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-01-0006852

Recognitions & Rankings of Lalco Pharma

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-DL-01-0006852

Contact details

Lalco Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    62/14 Old Rajinder Nagar, New Delhi, Delhi, India – 110060
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Lalco Pharma Private Limited, buy the company report.

Comprehensive company report
Lalco Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Lalco Pharma is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Lalco Pharma Private Limited, buy the company report.

Financials of Lalco Pharma Private Limited

FY 2025 filings available

Lalco Pharma Private Limited reported revenue of ₹21.01 Cr (down 4% YoY) for FY 2025.

Revenue · FY 2025
₹21.01 Cr ▼ 4%
Net profit · FY 2025
₹25.53 Lakh margin 1.2%
EBITDA · FY 2025
₹66.94 Lakh margin 3.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 4%
3 years · compounded
▲ 8%
5 years · compounded
▲ 2%
EBITDA CAGR growth
1 year
▲ 12%
3 years · compounded
▲ 14%
5 years · compounded
▲ 6%

Revenue fell 4% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 2%. EBITDA rose 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹66.94 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹25.53 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin3.2%
Net Profit Margin1.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Lalco Pharma Private Limited, buy the company report.

Board of directors of Lalco Pharma Private Limited

Lalco Pharma has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Abhay Kumar AgarwalManaging Director13 Mar 200026 Years 7 MonthsCurrent
Atul Kumar AgarwalDirector13 Mar 200026 Years 7 MonthsCurrent
Ajay Kumar AggarwalDirector13 Mar 200026 Years 7 MonthsCurrent
Anup Kumar AggarwalDirector13 Mar 200026 Years 7 MonthsCurrent

Peer comparison

Lalco Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Madhu Malti Enterprises Private Limited₹21.21 Cr (FY 2024)10.0%Mumbai, Maharashtra, India
Crystal Distributors Private Limited₹21.12 Cr (FY 2025)2.0%Ahmedabad, Gujarat, India
Lalco Pharma Private Limitedthis company₹21.01 Cr (FY 2025)₹25.53 Lakh1.2%-4.0%New Delhi, Delhi, India
Mooval Distributors Private Limited₹20.87 Cr (FY 2025)-13.0%Malappuram, Kerala, India

To see the full peer comparison of Lalco Pharma Private Limited, buy the company report.

Auditor

Lalco Pharma Private Limited is audited by K S GUPTA & CO. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
K S GUPTA & CO.FY 2023001180N

Shareholding

The shareholding of Lalco Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Lalco Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹6.22 Cr
Satisfied charges
None
Breakdown by lending institutions
Others₹5.14 Cr
Union Bank of India₹1.08 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
19 May 2025101096275Others₹4.9 CrOpen
02 Jun 2020100370937Others₹15 LakhOpen
29 May 2020100370936Others₹9 LakhOpen
12 Oct 200190036817Union Bank of India₹18 LakhOpen
18 Dec 200090036260Union Bank of India₹90 LakhOpen

To see the full charge records of Lalco Pharma Private Limited, buy the company report.

Total charge records: 5 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Lalco Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Lalco Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
07AAACL7439D1ZMDelhiActive01 Jul 2017

To see the full GST registrations and return filing status of Lalco Pharma Private Limited, buy the company report.

Recent activity

Lalco Pharma Private Limited has 6 board changes on record since 2000: 4 appointments and 2 cessations. The latest: Sudha Rani Aggarwal ceased to be Director on 09 Jan 2020.

Charges
A charge with Others of Rs. 490.00 Lakh registered on 19 May 2025 with Charge ID 101096275 was modified on 24 Oct 2025.
AGM
Lalco Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 490.00 Lakh with Charge ID 101096275 was registered on 19 May 2025.
Filing
Lalco Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Charges
A charge with Others amounted to Rs. 15.00 Lakh with Charge ID 100370937 was registered on 02 Jun 2020.
Charges
A charge with Others amounted to Rs. 9.00 Lakh with Charge ID 100370936 was registered on 29 May 2020.
Ceased
Sudha Rani Aggarwal ceased to be Director.
Ceased
Abhay Kumar Agarwal ceased to be Director.
Charges
A charge with Union Bank Of India of Rs. 90.00 Lakh registered on 18 Dec 2000 with Charge ID 90036260 was modified on 29 Mar 2014.
Charges
A charge with Union Bank Of India of Rs. 18.00 Lakh registered on 12 Oct 2001 with Charge ID 90036817 was modified on 06 Feb 2003.
Charges
A charge with Union Bank Of India amounted to Rs. 18.00 Lakh with Charge ID 90036817 was registered on 12 Oct 2001.
Charges
A charge with Union Bank Of India amounted to Rs. 90.00 Lakh with Charge ID 90036260 was registered on 18 Dec 2000.

5 earlier events are in the company report.

Frequently asked questions

Lalco Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 March 2000 (26+ years old) and is registered under CIN U24239DL2000PTC104377.

Lalco Pharma has 4 current directors:

The latest financial statements of Lalco Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Lalco Pharma is 07AAACL7439D1ZM, registered in Delhi.

The CIN (Corporate Identification Number) of Lalco Pharma is U24239DL2000PTC104377. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Lalco Pharma has 1 court case on record: 1 filed against it.

Lalco Pharma was incorporated on 13 March 2000, making it 26+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Lalco Pharma by revenue are Madhu Malti Enterprises Private Limited, Crystal Distributors Private Limited, Mooval Distributors Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).

Sudha Rani Aggarwal ceased to be Director on 09 Jan 2020. Abhay Kumar Agarwal ceased to be Director on 12 Mar 2015. Abhay Kumar Agarwal was appointed as Managing Director on 13 Mar 2000. Lalco Pharma has 6 board changes on record in total.

Yes, Lalco Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-DL-01-0006852).

The registered office of Lalco Pharma is at 6214 Old Rajinder Nagar, New Delhi, Delhi, India – 110060.